Emotional Dysregulation in Para-suicidal Behavior

Launched by HAUKELAND UNIVERSITY HOSPITAL · Feb 18, 2019

Keywords

ClinConnect Summary

This clinical trial, titled "Emotional Dysregulation in Para-suicidal Behavior," is studying how people who struggle with self-harm and suicidal thoughts can improve their emotional skills through a specific type of therapy called Dialectical Behavior Therapy (DBT). The researchers want to understand how changes in emotional processing—the way people experience and manage their emotions—can relate to successfully reducing self-injury and suicidal thoughts. They will look at how often and intensely these behaviors occur and how they connect to challenges in regulating emotions.

To be eligible for this trial, participants must be individuals receiving standard outpatient DBT treatment for issues like self-harm or suicidal thoughts. The study welcomes people of all genders and is open to ages ranging from 16 to 74. Participants will complete questionnaires and may undergo some physiological assessments to help researchers understand their emotional regulation. It's important to note that those with serious neurological or cardiac conditions, or severe psychiatric illnesses, will not be included in the study. Overall, this research aims to find better ways to support individuals facing these difficult emotional challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria Patients:
• • Patients with non-suicidal self-injury and/or suicidal ideation that undergo standard clinical outpatient DBT treatment will be recruited.
• Exclusion Criteria Patients:
• • Lack of informed consent
• Exclusion Criteria Healthy Controls:
• • Lack of informed consent
• • former or current neurological conditions
• • severe psychiatric illness
• • cardiac conditions.